Acrospire Investment Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,642	Closed	-$18K	–	2558
2017 Q1	$18K	Buy	12,642 +1,876	+17%	+$2.67K	0.01%	1674
2016 Q4	$13K	Buy	10,766 +7,066	+191%	+$8.53K	0.01%	1909
2016 Q3	$5K	Buy	3,700 +1,400	+61%	+$1.89K	﹤0.01%	1827
2016 Q2	$3K	Buy	+2,300	New	+$3K	﹤0.01%	1923